Mesirow Financial Investment Management’s AbbVie ABBV Stock Holding History

Mesirow Financial Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40M	Buy	158,995 +459	+0.3%	+$98.8K	0.63%	38
2026 Q1	$34.5M	Buy	158,536 +8,023	+5%	+$1.78M	0.56%	47
2025 Q4	$34.4M	Sell	150,513 -11,986	-7%	-$2.73M	0.71%	32
2025 Q3	$37.6M	Buy	162,499 +3,722	+2%	+$758K	0.67%	35
2025 Q2	$29.5M	Sell	158,777 -1,419	-0.9%	-$264K	0.57%	43
2025 Q1	$33.6M	Sell	160,196 -9,276	-5%	-$1.8M	0.65%	33
2024 Q4	$30.1M	Buy	169,472 +4,260	+3%	+$783K	0.6%	39
2024 Q3	$32.6M	Sell	165,212 -1,369	-0.8%	-$256K	0.63%	40
2024 Q2	$28.6M	Sell	166,581 -13,644	-8%	-$2.26M	0.64%	37
2024 Q1	$32.8M	Buy	180,225 +35,312	+24%	+$6.09M	0.75%	29
2023 Q4	$21.4M	Buy	+144,913	New	+$21.1M	0.78%	30

Other funds holding ABBV

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Mesirow Financial Investment Management's ABBV Position: Q2 2026 in Review

Mesirow Financial Investment Management increased its AbbVie (ABBV) stake by 0.29% in Q2 2026, buying an estimated $98.8K and bringing the position to 158,995 shares worth $40M. The position accounts for 0.63% of the portfolio, ranked #38.

Mesirow Financial Investment Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Mesirow Financial Investment Management held 158,995 shares of AbbVie worth $40M as of Q2 2026.
Mesirow Financial Investment Management bought 459 AbbVie shares in Q2 2026, an estimated $98.8K.
AbbVie made up 0.63% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #38 holding.
Mesirow Financial Investment Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
2,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.